• 목록
• 답변
• 글쓰기
• 게시판 리스트 옵션
  • 수정
  • 삭제

ADHD Medication During Pregnancy and Breastfeeding

Women with ADHD have to make a difficult choice about whether to continue or stop taking ADHD medication during pregnancy and breast-feeding. There isn't much information on how long-term exposure to these medications can affect the fetus.

A recent study published in Molecular Psychiatry shows that children exposed to ADHD medication during the uterus do not develop neurological developmental disorders like hearing or vision impairment seizures, febrile seizures or IQ impairment. The authors acknowledge the need for higher-quality studies.

Risk/Benefit Analysis

Women who are expecting and taking ADHD medication need to evaluate the benefits of using it versus the dangers for the baby. Doctors don't have enough data to give clear advice but they can provide information on risks and benefits to aid pregnant women in making informed choices.

A study published in Molecular Psychiatry found that women who took ADHD medications in early pregnancy did not face an increased risk of fetal cardiac malformations or major birth defects that are structural. Researchers used a vast, population-based case-control study to assess the risk of major structural birth defects in infants born to mothers who had taken stimulants in the early stages of pregnancy and those who had not. Pediatric cardiologists, clinical geneticists and other experts reviewed the cases in order to ensure that the classification was correct and to reduce any bias.

However, the study had its limitations. The researchers were not able to, in the first place to distinguish the effects caused by the medication from the disorder. That limitation makes it difficult to determine whether the limited associations observed in the groups that were exposed are due to the use of medication or the confounding effect of comorbidities. In addition the study did not study the long-term effects of offspring on their parents.

The study showed that infants whose mother had taken ADHD medication during pregnancy had a slightly greater risk of being admitted to the neonatal care unit (NICU) in comparison to those whose mothers did not use any medication during pregnancy or had quit taking the medication prior to or during pregnancy. The reason for this was central nervous system-related disorders, and the increased risk for admission did not appear to be affected by the type of stimulant medications were taken during pregnancy.

Women who used stimulant ADHD medication during pregnancy also had an increased chance of having a caesarean birth or having a baby born with low Apgar score (less than 7). These increases appeared to be independent of the type of medication used during pregnancy.

Researchers suggest that the minor risks posed by the use of ADHD medications in early pregnancies could be offset by the greater benefits for mother and baby of continuing treatment for the woman's disorder. Physicians should speak with their patients about this issue and try to help them develop coping skills that can lessen the effects of her disorder on her daily functioning and her relationships.

Medication Interactions

As more women than ever before are being diagnosed with ADHD and being treated with medication, the dilemma of whether to continue or end treatment during pregnancy is one that more and more doctors have to face. These decisions are frequently made without clear and authoritative evidence. Instead, doctors must weigh their own knowledge, the experience of other physicians and the research on the subject.

The issue of possible risks to infants is difficult to determine. Many of the studies on this topic are based on observational evidence rather than controlled research and their findings are often contradictory. The majority of studies limit their analysis to live births, which may underestimate the teratogenic impact leading to abortions or terminations of pregnancy. The study discussed in this journal club addresses these limitations by analyzing data on live and deceased births.

Conclusion Some studies have revealed a positive correlation between ADHD medications and certain birth defects however, other studies haven't established a link. most popular adhd Medication studies have shown that there is a neutral, or somewhat negative, impact. Therefore, a careful risk/benefit assessment is required in every case.

For a lot of women with ADHD who suffer from ADHD, the decision to stop medication can be difficult, if not impossible. In fact, in an article published in Archives of Women's Mental Health, psychologist Jennifer Russell notes that stopping ADHD medication during pregnancy can lead to increased depression, feelings of loneliness and family conflict for those suffering from the disorder. Furthermore, a loss of medication may affect the ability to complete work-related tasks and safely drive which are essential aspects of daily life for many people with ADHD.

She suggests that women who aren't sure whether to continue taking the medication or stop due to pregnancy, educate their family members, coworkers, and friends about the condition, the impact on daily functioning and the benefits of continuing the current treatment. It can also help women feel confident about her decision. Some medications can pass through the placenta. If a patient decides to not take her ADHD medication while breastfeeding, it is crucial to be aware that the medication could be passed on to her infant.

Birth Defects Risk

As the use of ADHD medications to treat symptoms of attention deficit hyperactivity disorder (ADHD) increases as do concerns about what impact the drugs might have on the fetuses. A recent study published in the journal Molecular Psychiatry adds to the body of knowledge about this subject. Researchers used two massive data sets to examine more than 4.3 million pregnancies and determine whether stimulant medications increased birth defects. Researchers found that while the overall risk is low, the first trimester ADHD medication use was associated with slightly higher risk of specific heart defects such as ventriculoseptal defect.

The researchers of the study could not discover any link between the use of early medications and congenital anomalies like facial deformities, or club feet. The results are in the same vein as previous studies which showed a small, but significant increase in the number of cardiac malformations among women who began taking ADHD medication prior to the time of the birth of their child. The risk increased in the latter stages of pregnancy when many women decided to stop taking their medication.

Women who took ADHD medication in the first trimester of pregnancy were also more likely to undergo caesarean section, low Apgar score after delivery and a baby that required breathing assistance during birth. The researchers of the study could not eliminate bias due to selection because they limited their study to women with no other medical conditions that could have contributed to the findings.

The researchers hope their study will serve to inform the clinical decisions of doctors who see pregnant women. They suggest that although a discussion of risks and benefits is important, the decision to stop or continue medication must be based on each woman's requirements and the severity of her ADHD symptoms.

The authors caution that, while stopping adhd medication adults the medication is an option to consider, it is not recommended due to the high rate depression and mental health issues in women who are expecting or recently gave birth. Further, the research suggests that women who decide to stop their medications are more likely to have difficulties adapting to life without them after the baby's arrival.

Nursing

It can be overwhelming to become a mom. Women with ADHD who have to deal with their symptoms while attending physician appointments and getting ready for the arrival of their child and getting used to new routines at home can experience severe challenges. This is why many women decide to continue taking their ADHD medications throughout the course of pregnancy.

The majority of stimulant drugs pass through breast milk in low amounts, so the risk for infant who is breastfeeding is low. The rate of medication exposure can vary depending upon the dosage, frequency of administration and time of day. Additionally, individual medications enter the body of the baby differently through the gastrointestinal tract as well as breast milk, and the effect of this on a newborn infant is not fully understood.

Because of the lack of research, some doctors might be tempted to stop taking stimulant drugs during the pregnancy of a woman. This is a difficult choice for the patient, who must balance the benefits of continuing her medication against the possible risks to the foetus. Until more information becomes available, doctors can ask pregnant patients if they have any history of ADHD or if they intend to take medication during the perinatal phase.

Many studies have shown that women can continue to take their ADHD medication safely during pregnancy and while breast-feeding. In the end, many patients are choosing to do so and in consultation with their physician, they have discovered that the benefits of maintaining their current medication far exceed any risk.

It is crucial for women suffering from ADHD who are contemplating breastfeeding to seek out a specialist psychiatrist's advice prior becoming pregnant. They should discuss their medication with their prescriber, and the pros and cons of continuing treatment. This includes non-pharmacological strategies. Psychoeducation is also necessary to help pregnant women with ADHD be aware of the symptoms and underlying disorder. They should also learn about treatment options and reinforce coping mechanisms. This should involve a multidisciplinary approach with the GP doctors, obstetricians and psychiatrists. The pregnancy counselling should consist of the discussion of a plan for management for both mother and child, and monitoring for signs of deterioration and, if necessary, adjustments to the medication regimen.